22-45518772-A-C
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2
The NM_006486.3(FBLN1):āc.170A>Cā(p.Glu57Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000096 in 1,458,316 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_006486.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
FBLN1 | NM_006486.3 | c.170A>C | p.Glu57Ala | missense_variant | 2/17 | ENST00000327858.11 | |
FBLN1 | NM_001996.4 | c.170A>C | p.Glu57Ala | missense_variant | 2/15 | ||
FBLN1 | NM_006485.4 | c.170A>C | p.Glu57Ala | missense_variant | 2/15 | ||
FBLN1 | NM_006487.3 | c.170A>C | p.Glu57Ala | missense_variant | 2/15 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
FBLN1 | ENST00000327858.11 | c.170A>C | p.Glu57Ala | missense_variant | 2/17 | 1 | NM_006486.3 | P1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000412 AC: 1AN: 242936Hom.: 0 AF XY: 0.00000761 AC XY: 1AN XY: 131324
GnomAD4 exome AF: 0.00000960 AC: 14AN: 1458316Hom.: 0 Cov.: 32 AF XY: 0.0000110 AC XY: 8AN XY: 725046
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 20, 2023 | The c.170A>C (p.E57A) alteration is located in exon 2 (coding exon 2) of the FBLN1 gene. This alteration results from a A to C substitution at nucleotide position 170, causing the glutamic acid (E) at amino acid position 57 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at